Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 39.88 Million JPY | 383.24% |
| 2022 | 8.25 Million JPY | 0.0% |
| 2021 | - JPY | -100.0% |
| 2020 | 37.78 Million JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.03 Million JPY | -45.97% |
| 2024 Q2 | 4.74 Million JPY | -5.7% |
| 2023 Q3 | 13.33 Million JPY | 10.64% |
| 2023 FY | 39.88 Million JPY | 383.24% |
| 2023 Q2 | 12.05 Million JPY | 132.73% |
| 2023 Q1 | 5.17 Million JPY | -3.83% |
| 2023 Q4 | 9.32 Million JPY | -30.11% |
| 2022 Q3 | 2.86 Million JPY | 0.0% |
| 2022 FY | 8.25 Million JPY | 0.0% |
| 2022 Q4 | 5.38 Million JPY | 87.7% |
| 2021 FY | - JPY | -100.0% |
| 2020 FY | 37.78 Million JPY | 0.0% |
| 2019 FY | - JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 99.164% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | 64.679% |
| GNI Group Ltd. | 26.01 Billion JPY | 99.847% |
| Linical Co., Ltd. | 12.3 Billion JPY | 99.676% |
| Trans Genic Inc. | 13.08 Billion JPY | 99.695% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 93.971% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 99.227% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 97.444% |
| AnGes, Inc. | 152.98 Million JPY | 73.928% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 93.462% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 99.688% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 95.116% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | 70.565% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 97.547% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 90.689% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 97.902% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 94.155% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 98.359% |
| PeptiDream Inc. | 28.71 Billion JPY | 99.861% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | 36.725% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | 67.036% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -55298.611% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 99.116% |
| FunPep Company Limited | 530 Thousand JPY | -7425.849% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 42.401% |
| Stella Pharma Corporation | 269.49 Million JPY | 85.199% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 87.41% |
| Cuorips Inc. | 23.1 Million JPY | -72.656% |
| K Pharma,Inc. | 1 Billion JPY | 96.011% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.908% |
| ReproCELL Incorporated | 2.42 Billion JPY | 98.356% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 97.675% |
| StemCell Institute Inc. | 2.48 Billion JPY | 98.392% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 98.414% |
| CellSeed Inc. | 190.13 Million JPY | 79.022% |